High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer’s disease
Abstract Background Recent advances in blood-based biomarker discovery are paving the way for simpler, more accessible diagnostic tools that can detect early signs of Alzheimer’s disease (AD). Recent successes in the development of amyloid-targeting immunotherapy approaches mark an important advance...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2024-10-01
|
| Colección: | Alzheimer’s Research & Therapy |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s13195-024-01561-1 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
